Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Bortezomib × Clear all

Sponsor

Conditions

Multiple Myeloma 152 Lymphoma, Mantle-Cell 30 Lymphoma, Non-Hodgkin 22 Lymphoma, Follicular 22 Lymphoma 22 Recurrence 21 Neoplasms, Plasma Cell 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Leukemia, Myeloid, Acute 12 Waldenstrom Macroglobulinemia 11 Lymphoma, Large B-Cell, Diffuse 11 Immunoglobulin Light-chain Amyloidosis 10 Neoplasms 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Lymphoma, B-Cell 7 Leukemia 6 Carcinoma, Non-Small-Cell Lung 6 Myelodysplastic Syndromes 5 Hematologic Neoplasms 5 Brain Neoplasms 5 Amyloidosis 5 Lymphoma, Large-Cell, Immunoblastic 4 Hematologic Diseases 4 Congenital Abnormalities 4 Paraproteinemias 3 Leukemia, Myelomonocytic, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Erythroblastic, Acute 3 Leukemia, B-Cell 3

Interventions

Pemetrexed 12 Cisplatin 11 pembrolizumab 8 Carboplatin 6 Ipilimumab 5 Nivolumab 4 LMB-100 4 durvalumab 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 spartalizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡